Hematological cancers vary significantly in both prognosis and aggressiveness, demonstrating a need for tools that assist pathologists in making confident diagnoses and helping to inform clinical decisions1,2,3. We offer over 65 cornerstone and novel hematopathology ready-to-use reagents, including key IHC antibodies and ISH probes, which aid in lymphoma diagnostics, leukemia diagnostics, myeloma diagnostics and other hematopoietic malignancies.
Our robust menu of tools aid in hematopathology diagnostics and treatment. Our portfolio of immunohistochemistry detection products delivers the high sensitivity and specificity you need from your assays. Our antibodies are ready-to-use on the fully-automated VENTANA BenchMark IHC/ISH staining platforms, reducing the time-to-result and resources required with manual or semi-automated solutions.
CONFIRM anti-CD20 (L26) Primary Antibody is a mouse monoclonal antibody (IgG2a, kappa) directed against an epitope present on human B lymphocytes. This antibody is intended for use to qualitatively identify cells of B lymphocytic lineage.
CONFIRM anti-CD3 (2GV6) is a rabbit monoclonal antibody (IgG) directed against the nonglycosylated epsilon chain of the human CD3 molecule. This antibody is intended for use to qualitatively identify T cells.
bcl-2 (SP66) Rabbit Monoclonal Primary Antibody is directed against human bcl-2 expressed by B cells of the mantle zone and interfollicular T cells. This antibody exhibits a cytoplasmic staining pattern and may be used to aid in the identification of follicular lymphomas and diffuse large cell lymphomas
CD30 (Ber-H2) positive staining results may aid in the identification of classical Hodgkin lymphoma and anaplastic large cell lymphoma.
c-MYC (Y69) Rabbit Monoclonal Primary Antibody is directed against the transcription factor c-MYC, an important factor in cell cycle regulation. The anti-c-MYC (Y69) antibody exhibits a nuclear staining pattern and may be used to aid in the characterization of lymphoma.
VENTANA anti-Cyclin D1 (SP4-R) Rabbit Monoclonal Primary Antibody is directed against the Cyclin D1 molecule, a key cell cycle regulator, expressed primarily during the G1 phase of the cell cycle. This antibody exhibits a nuclear staining pattern, and may be used to aid in the identification of mantle cell lymphoma and breast carcinoma.